Mark Wilkinson
Angel Investor
Sydney, Australia
Mark Wilkinson is an English-Australian singer-songwrite.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mark Wilkinson invests in
Stages Mark Wilkinson invests in
Countries Mark Wilkinson invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GrowLab Organics
|
GrowLab Organics is a medical cannabis company to increase access, affordability, choice, and quality while building an inclusive and community-owned business that acts as a positive force for change. | $1.2M / Seed / Jun 05, 2023 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Featured in Investor Lists
Recommended lists
FAQ
What does Mark Wilkinson invest in?
Mark Wilkinson invests primarily in Alternative Medicine startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Isle of Man. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Mark Wilkinson last invest?
The most recent investment recorded for Mark Wilkinson closed in Jun 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
